Mon, May 24, 2021
Fri, May 21, 2021
Thu, May 20, 2021

Eliana Merle Initiated (ZNTL) at Strong Buy and Held Target at $91 on, May 21st, 2021

Eliana Merle of UBS, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $91 on, May 21st, 2021.

Eliana has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Eliana's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Eliana


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $80 on, Wednesday, May 19th, 2021
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $64 on, Tuesday, April 13th, 2021